“SGLT2 inhibitors and GLP-1 receptor agonist: mechanisms of beneficial action beyond

Authors

Katherine Tuttle, ProvidenceFollow

Document Type

Presentation

Publication Date

10-1-2023

Keywords

washington; pmrc

Clinical Institute

Kidney & Diabetes

Comments

59th EASD Annual Meeting